Latest Breaking News On - Protocol chair - Page 1 : comparemela.com

Oral Zoliflodacin Noninferior to Standard of Care for Uncomplicated Gonorrhea

Treatment with oral zoliflodacin was found to be noninferior to ceftriaxone and oral azithromycin for the treatment of gonorrhea infection.

Drug administrationGlobal antibiotic research development partnershipUniversity of alabamaGlobal antibiotic researchDevelopment partnershipInnoviva specialtyProtocol chairEmeritus professor

Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to T

A Phase 3 study of oral zoliflodacin met the primary endpoint when compared against the combination of injectable ceftriaxone and oral azithromycin, a current international standard of care.Positive top-line study results are a significant milestone in the development of a first-in-class antibiotic against drug-resi.

South africaUnited kingdomUnited statesGrand duchy of luxembourgManica balasegaramDavid pattiPavel raifeldGlobal antibiotic research development partnershipLeo model foundationCorporate communicationsAfrican medical research councilUs national institute of allergyEntasis therapeutics incPublic health agency of canadaDrug administrationWorld health organization

Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea

A Phase 3 study of oral zoliflodacin met the primary endpoint when compared against the combination of injectable ceftriaxone and oral azithromycin, a current international standard of.

South africaUnited kingdomUnited statesGrand duchy of luxembourgManica balasegaramPavel raifeldEntasis therapeuticsDrug administrationWorld health organizationUniversity of alabamaPublic health agency of canadaLeo model foundationJolla pharmaceutical companyUs national institute of allergyAfrican medical research councilGlobal antibiotic research development partnership

Innoviva Specialty Therapeutics: Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea

Innoviva Specialty Therapeutics: Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South africaUnited statesUnited kingdomGrand duchy of luxembourgManica balasegaramDavid pattiPavel raifeldInnoviva incPublic health agency of canadaUniversity of alabamaEntasis therapeuticsJolla pharmaceutical companyDrug administrationAfrican medical research councilLeo model foundationUs national institute of allergy

ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023

ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesHeather ribaudoJudith currierPamelas douglasSteven grinspoonLos angelesMichael luKowa pharmaceuticals america incHarvard medical schoolNational heartBlood instituteNational institutes of healthClinical trials groupData coordinating centerGilead sciences incUniversity of california